MDF strongly encourages patients, families, clinicians, and researchers to respond to the NIH’s Request for Information on the Wellstone Center Program.
A new U.S. National Academy of Sciences (NAS) report—Returning Individual Research Results to Participants: Guidance for a New Research Paradigm—should be read by all clinical researchers.
The OPTIMISTIC clinical evaluation of exercise training and cognitive behavioral therapy paradigms comes to publication.
Feasibility is demonstrated in mammalian models for a therapeutic strategy that increases MBNL by sequestering MBNL-suppressive miRs.
That’s a wrap! The first-ever A Damn Good Time: Party to Make Myotonic Dystrophy History (#DGT4MDF) was held Thursday, June 7th at Sony Hall in New York City.
The University of Rochester held a tribute program entitled “A Celebration of a Pioneering Career in Neuromuscular Disease” May 31- June 1, 2018 in honor and celebration of Richard T. Moxley’s distinguished career as a clinician and researcher with a significant focus and commitment to myotonic dystrophy. MDF created a short video to celebrate Dr. Moxley's incredible impact.
MDF strongly encourages DM investigators to apply for research grant support from the Department of Defense's Peer-Reviewed Medical Research Program (PRMRP).
The Myotonic Dystrophy Foundation honored both Senator Dick Durbin and Senator Diane Feinstein with MDF Congressional Leadership Awards for their outstanding work and support in getting myotonic dystrophy added as an eligible research area in the U.S. Department of Defense (DOD) Peer-Reviewed Medical Research Program (PRMRP) for Fiscal Year 2018 (FY18).
- 1 of 38
- next ›